How early is early treatment?
Professor Aksel Siva from the University of Istanbul, Turkey, discusses the considerations for starting patients on disease-modifying therapy early in the disease course.
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now